At the 2023 Uromigos Live & Unplugged event, Pedro Barata, MD, University Hospitals Seidman Cancer Center, discussed his thoughts on the CheckMate 901 study and the use of cisplatin in patients with bladder cancer.
Uromigos Live 2023: Dr. Pedro Barata on Cisplatin for Bladder Cancer
By Pedro Barata, MD - Last Updated: November 10, 2023Post Tags:Uromigos Live 2023-Bladder Cancer
Related Posts
Dr. Powles chaired a livestreamed RCC session that included lively discussion from Drs. Atkins, McDermott, and Rini.
The panel highlights a serious of relevant studies in renal cell carcinoma, including CONTACT-03 and TiNivo-2.
The panel discusses data related to RLTs in prostate cancer, including a recap of the VISION trial and the PSMAfore trial.
The panel breaks down the details of the PROpel, TALAPRO-2, and MAGNITUDE trials along with relevant rPFS and HR data.
The panel discussed the latest updates in NMIBC, including relevant data pertaining to pembro, atezo, and more.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.